JP2002513801A5 - - Google Patents

Download PDF

Info

Publication number
JP2002513801A5
JP2002513801A5 JP2000547108A JP2000547108A JP2002513801A5 JP 2002513801 A5 JP2002513801 A5 JP 2002513801A5 JP 2000547108 A JP2000547108 A JP 2000547108A JP 2000547108 A JP2000547108 A JP 2000547108A JP 2002513801 A5 JP2002513801 A5 JP 2002513801A5
Authority
JP
Japan
Prior art keywords
missing
phe
aib
acc
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000547108A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002513801A (ja
JP4460157B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/009521 external-priority patent/WO1999057139A2/en
Publication of JP2002513801A publication Critical patent/JP2002513801A/ja
Publication of JP2002513801A5 publication Critical patent/JP2002513801A5/ja
Application granted granted Critical
Publication of JP4460157B2 publication Critical patent/JP4460157B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000547108A 1998-05-05 1999-05-03 Pth2レセプター選択的化合物 Expired - Fee Related JP4460157B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7295698A 1998-05-05 1998-05-05
US09/072,956 1998-05-05
PCT/US1999/009521 WO1999057139A2 (en) 1998-05-05 1999-05-03 Pth2 receptor selective compounds

Publications (3)

Publication Number Publication Date
JP2002513801A JP2002513801A (ja) 2002-05-14
JP2002513801A5 true JP2002513801A5 (cg-RX-API-DMAC7.html) 2006-02-16
JP4460157B2 JP4460157B2 (ja) 2010-05-12

Family

ID=22110801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000547108A Expired - Fee Related JP4460157B2 (ja) 1998-05-05 1999-05-03 Pth2レセプター選択的化合物

Country Status (12)

Country Link
US (2) US7531621B1 (cg-RX-API-DMAC7.html)
EP (1) EP1075491B1 (cg-RX-API-DMAC7.html)
JP (1) JP4460157B2 (cg-RX-API-DMAC7.html)
AT (1) ATE392431T1 (cg-RX-API-DMAC7.html)
AU (1) AU3673699A (cg-RX-API-DMAC7.html)
CA (1) CA2327509A1 (cg-RX-API-DMAC7.html)
DE (1) DE69938548T2 (cg-RX-API-DMAC7.html)
ES (1) ES2302374T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0300891A2 (cg-RX-API-DMAC7.html)
NO (1) NO20005556L (cg-RX-API-DMAC7.html)
PL (1) PL344645A1 (cg-RX-API-DMAC7.html)
WO (1) WO1999057139A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ106299A3 (cs) 1996-09-26 1999-08-11 Chugai Seiyaku Kabushiki Kaisha Protilátky proti proteinu příbuznému s lidským parathyroidálním hormonem
WO1998051329A1 (en) 1997-05-15 1998-11-19 Chugai Seiyaku Kabushiki Kaisha Cachexia remedy
WO2001002011A1 (fr) * 1999-07-02 2001-01-11 Chugai Seiyaku Kabushiki Kaisha REMEDES CONTRE LES MALADIES CAUSEES PAR PTH OU PTHrP
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
WO2001082968A1 (fr) 2000-04-28 2001-11-08 Chugai Seiyaku Kabushiki Kaisha Inhibiteurs de proliferation cellulaire
AU2001292905A1 (en) * 2000-09-19 2002-04-02 Curagen Corporation Method of identifying osteoregenerative agents using differential gene expression
WO2004071396A2 (en) * 2003-02-17 2004-08-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with parathyroid hormone receptor 2 (pthr2)
SI2084183T1 (sl) 2006-10-13 2010-09-30 Lilly Co Eli Pegilirani pth kot modulatorji pth receptorja in njihove uporabe
BRPI0814962B8 (pt) * 2007-08-01 2021-05-25 Chugai Pharmaceutical Co Ltd métodos in vitro para determinar se um composto candidato é um agonista de longa duração ou de curta duração de um receptor acoplado à proteína g, polipeptídeo, seu uso e composição farmacêutica
CN103002906B (zh) 2010-05-13 2017-12-29 总医院有限公司 甲状旁腺激素类似物及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293158A3 (en) 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid hormone antagonists
US5001223A (en) * 1987-05-26 1991-03-19 Merck & Co., Inc. Parathyroid hormone antagonists with enhanced metabolic properties
US5527772A (en) 1987-10-20 1996-06-18 Holick; Michael F. Regulation of cell proliferation and differentiation using peptides
EP0341962B1 (en) 1988-05-09 1995-03-15 Merck & Co. Inc. Humoral hypercalcemic factor antagonists
US4968669A (en) 1988-05-09 1990-11-06 Merck & Co., Inc. Parathyroid hormone antagonists
CA2040264A1 (en) 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
US5093233A (en) 1990-04-25 1992-03-03 Merck & Co., Inc. Antagonists with position 13 modification
US5087562A (en) 1990-04-25 1992-02-11 Merck & Co., Inc. Humoral hypercalcemic factor antagonists with modification at position 13 . . .
US5149779A (en) 1990-07-26 1992-09-22 Merck & Co., Inc. Humoral hypercalcemic factor antagonists
JPH0532696A (ja) 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
WO1992011286A1 (en) * 1990-12-21 1992-07-09 Allelix Biopharmaceuticals Inc. Oxidation resistant variants of parathyroid hormone
DE4203040A1 (de) 1992-02-04 1993-08-05 Boehringer Mannheim Gmbh Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel
US5589452A (en) 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
US5556940A (en) * 1994-06-20 1996-09-17 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
US5747456A (en) * 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
US5717062A (en) 1995-06-07 1998-02-10 Beth Israel Hospital Association Cyclic analogs of PTH and PTHrP
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
US5955574A (en) * 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
US5969095A (en) 1995-07-13 1999-10-19 Biomeasure, Inc. Analogs of parathyroid hormone
JP3259011B2 (ja) * 1995-08-02 2002-02-18 ミヤチテクノス株式会社 インバータ式抵抗溶接制御方法及び装置
AU3819497A (en) 1996-07-31 1998-02-20 General Hospital Corporation, The Novel parathyroid hormone-related peptide analogs

Similar Documents

Publication Publication Date Title
TWI221845B (en) Peptide analogues
US5084555A (en) An octapeptide bombesin analog
FI92326C (fi) LHRH:n nonapeptidi- ja dekapeptidianalogeja, jotka ovat käyttökelpoisia LHRH:n antagonisteina
CN100412091C (zh) 甲状旁腺素类似物
EP1792915A3 (en) Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
US5877277A (en) Octapeptide bombesin analogs
US7410948B2 (en) Analogs of parathyroid hormone
JP2003510256A (ja) 骨粗鬆症治療用副甲状腺ホルモン類似体
JP2004520395A5 (cg-RX-API-DMAC7.html)
CA2157766A1 (en) Analogs of peptide yy and uses thereof
CA2284547A1 (en) Mu-opiate receptor peptides
EP2054438A1 (en) Truncated pth peptides with a cyclic conformation
JP2011032282A (ja) 改善された経口ペプチド送達
JP2009057386A (ja) 骨粗鬆症の治療のための副甲状腺ホルモン類似体
US5162497A (en) Bradykinin analogs with non-peptide bond
CA2416475A1 (en) Medicinal uses of mu-opioid receptor agonists
EP1015007A1 (en) Analogs of peptide yy and uses thereof
US7288517B2 (en) Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists
AU697829B2 (en) Superactive VIP antagonists
US5750646A (en) Bradykinin analogs with non-peptide bond
CN102160890A (zh) 包含止痛肽的药物组合物
HUT65465A (en) Process for producing the rapeutic peptides
WO1993020834A1 (en) Methods and compositions for oral delivery of therapeutic agents
JP2009502976A (ja) 親水性ペプチド鎮痛薬の経口送達のためのペプチドコンジュゲート
AU622123C (en) Therapeutic peptides